Equities

Hypera SA

Hypera SA

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (BRL)29.61
  • Today's Change-0.47 / -1.56%
  • Shares traded2.76m
  • 1 Year change-20.51%
  • Beta0.8320
Data delayed at least 15 minutes, as of Apr 30 2024 19:57 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • HYPE3:SAO reported earnings of 0.62 for the period of the year 2024Q1.
  • HYPE3:SAO price moved over +1.03% to 27.43
  • HYPE3:SAO price reached a new 52-week low of 27.40 at 17:11 BST
  • HYPE3:SAO trading volume exceeds daily average by +22.50%
  • HYPE3:SAO price falls below 15-day moving average to 29.26 at 13:30 BST
  • HYPE3:SAO price rises above 15-day moving average to 29.36 at 11:20 BST

Key statistics

As of last trade Hypera SA (HYPE3:SAO) traded at 29.61, 9.22% above its 52-week low of 27.11, set on Apr 25, 2024.
52-week range
Today
27.11Apr 25 202446.84Jul 05 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open29.92
High30.07
Low29.09
Bid29.60
Offer29.61
Previous close30.08
Average volume5.32m
Shares outstanding633.42m
Free float370.80m
P/E (TTM)11.26
Market cap19.05bn BRL
EPS (TTM)2.67
BRL
Annual div (ADY)--
Annual div yield (ADY)--
Div ex-dateApr 20 2017
Div pay-dateMay 02 2017
Data delayed at least 15 minutes, as of Apr 30 2024 19:57 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.